Heliyon: Difference between revisions
Content deleted Content added
Randykitty (talk | contribs) correct some references; streamline |
Randykitty (talk | contribs) tweak |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
{{Infobox journal |
{{Infobox journal |
||
| title |
| title = Heliyon |
||
| image |
| image = 2021 cover Heliyon.jpg |
||
| former_name |
| former_name = |
||
| abbreviation |
| abbreviation = Heliyon |
||
| discipline |
| discipline = [[Multidisciplinary]] |
||
| editor |
| editor = |
||
| publisher |
| publisher = [[Cell Press]] |
||
| country |
| country = |
||
| history |
| history = 2015–present |
||
| impact |
| impact = 3.4 |
||
| impact-year |
| impact-year = 2023 |
||
| frequency |
| frequency = Monthly |
||
| openaccess |
| openaccess = Yes |
||
| license |
| license = [[CC BY]] |
||
| ISSN |
| ISSN = |
||
| eISSN |
| eISSN = 2405-8440 |
||
| CODEN |
| CODEN = |
||
| JSTOR |
| JSTOR = |
||
| LCCN |
| LCCN = |
||
| OCLC |
| OCLC = 934910176 |
||
| website |
| website = https://www.cell.com/heliyon/home |
||
| link2 |
| link2 = https://www.sciencedirect.com/journal/heliyon/issues |
||
| link2-name |
| link2-name = Online archive |
||
}} |
}} |
||
'''''Heliyon''''' is a monthly [[peer-reviewed]] [[open-access]] [[mega journal]] covering research in science, medicine and engineering. Unlike most of its competitors, the journal will consider for publication works reporting negative/null results, incremental advances, and replication studies,<ref>{{Cite web |url=https://www.cell.com/heliyon/guide-for-authors |title=Cell Press: Heliyon}}</ref> thus filling the market niche, which became vacant after the discontinuation of the ''[[Journal of Negative Results in Biomedicine]]'' in 2017. |
'''''Heliyon''''' is a monthly [[peer-reviewed]] [[open-access]] [[mega journal]] covering research in science, medicine and engineering. Unlike most of its competitors, the journal will consider for publication works reporting negative/null results, incremental advances, and replication studies,<ref>{{Cite web |url=https://www.cell.com/heliyon/guide-for-authors |title=Cell Press: Heliyon}}</ref> thus filling the market niche, which became vacant after the discontinuation of the ''[[Journal of Negative Results in Biomedicine]]'' in 2017. |
||
| Line 42: | Line 42: | ||
*[[The Zoological Record]].<ref name=ISI/> |
*[[The Zoological Record]].<ref name=ISI/> |
||
}} |
}} |
||
{{As of|October 2024}}, the journal's indexation in the Science Citation Index Expanded is "on hold" pending re-evaluation, because "Concerns have been raised about the quality of the content published in this journal."<ref name=ISI/> |
|||
{{As of|October 2024}}, the journal's indexation in the Science Citation Index Expanded is "on hold" and pending re-evaluation, with [[Web of Science]] citing the concerns on "the quality of the content published in this journal" as a reason for the suspension.<ref name=ISI/><ref>{{cite web |last1=Joelving |first1=Frederik |title=Web of Science puts mega-journals Cureus and Heliyon on hold |url=https://retractionwatch.com/2024/09/30/web-of-science-puts-mega-journals-cureus-and-heliyon-on-hold/ |website=retractionwatch.com |publisher=[[Retraction Watch]] |access-date=October 12, 2024 |date=September 30, 2024}}</ref> |
|||
==References== |
==References== |
||
Latest revision as of 16:15, 15 October 2024
 | |
| Discipline | Multidisciplinary |
|---|---|
| Language | English |
| Publication details | |
| History | 2015–present |
| Publisher | |
| Frequency | Monthly |
| Yes | |
| License | CC BY |
| 3.4 (2023) | |
| Standard abbreviations | |
| ISO 4 | Heliyon |
| Indexing | |
| ISSN | 2405-8440 |
| OCLC no. | 934910176 |
| Links | |
Heliyon is a monthly peer-reviewed open-access mega journal covering research in science, medicine and engineering. Unlike most of its competitors, the journal will consider for publication works reporting negative/null results, incremental advances, and replication studies,[1] thus filling the market niche, which became vacant after the discontinuation of the Journal of Negative Results in Biomedicine in 2017.
Heliyon was established in 2015 by Cell Press, a division of Elsevier. According to the publisher's website: "the [journal's] name is all about shining light on important research. Helios was the Greek god of the sun. This root word gave us inspiration, as we want this journal to illuminate knowledge across a broad spectrum."[2]
The journal is divided into numerous sections, each with its own editorial team. Articles are published under a CC BY open access license.
Abstracting and indexing
[edit]The journal is abstracted and indexed in:
As of October 2024[update], the journal's indexation in the Science Citation Index Expanded is "on hold" and pending re-evaluation, with Web of Science citing the concerns on "the quality of the content published in this journal" as a reason for the suspension.[5][9]
References
[edit]- ^ "Cell Press: Heliyon".
- ^ "New open access journal Heliyon opens for submissions". www.elsevier.com.
- ^ "Serials cited". CAB Abstracts. CABI. Retrieved 2021-12-24.
- ^ "CAS Source Index". Chemical Abstracts Service. American Chemical Society. Retrieved 2024-10-12.
- ^ a b c d "Web of Science Master Journal List". Intellectual Property & Science. Clarivate . Retrieved 2021-12-24.
- ^ "Heliyon". Directory of Open Access Journals. Retrieved 2024-10-12.
- ^ "Heliyon". MIAR: Information Matrix for the Analysis of Journals. University of Barcelona. Retrieved 2021-12-24.
- ^ "Source details: Heliyon". Scopus Preview. Elsevier. Retrieved 2021-12-24.
- ^ Joelving, Frederik (September 30, 2024). "Web of Science puts mega-journals Cureus and Heliyon on hold". retractionwatch.com. Retraction Watch. Retrieved October 12, 2024.